We recently published an article titled Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

New study highlights the potential benefits of breast ultrasound as a supplemental screening tool for women with dense breast ...

One patient was incorrectly cleared of cancer, with her tumour going untreated for months, while the other reportedly ...

The catastrophic mix up is believed to have occurred at Pathology Queensland, a state-run service which offers bowel, breast ...

MEMPHIS, Tenn. (AP) — A Tennessee gynecologist was arrested Friday and accused of performing unnecessary procedures on patients with re-used medical devices held under unsanitary conditions.

(UroToday.com) The 2025 APCCC Diagnostics annual meeting featured a session on how to monitor metastatic prostate cancer and ...

The 18-gene MyProstateScore 2.0 biomarker test was designed to reduce overdiagnosis of low-grade prostate cancers.

Reported unprecedented, statistically significant reversal of compensated cirrhosis (F4) due to MASH after 96 weeks of treatment with ...

The firm said that its MyProstateScore 2.0 test delivers equivalent performance with samples collected at home or collected following digital rectal examination.

MPS2 provides meaningful improvement in detection of grade group ≥2 cancer relative to PSA-based testing approaches.

The Braidwood Management v Becerra decision could require payers to step up to continue covering preventive services, ...